A gene delivery vector used to generate genetically modified dendritic cells and B-cells central to the immune system. As a result, genetic modification of cells bearing the CD40 target antigen on its surface can be used to modulate immunity. Previously, both dendritic cells and B-cells have been resistant...http://www.google.es/patents/US6284742?utm_source=gb-gplus-sharePatente US6284742 - Immunomodulation by genetic modification of dendritic cells and B cells
Immunomodulation by genetic modification of dendritic cells and B cells
